AGP Picks
View all

Jordan Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Healthcare Press.

Press releases published on November 16, 2026

Prenetics’ IM8 Announces Three-Time GRAMMY-Winning DJ and Producer Diplo as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
HCW Biologics Reports Third Quarter 2026 Business and Clinical Development Highlights and Financial Results
XORTX Completes Manufacturing of Clinical Drug Supply
VivoSim Labs to Showcase Breakthrough Multiparametric NAMkind™ Liver and Intestine Data at the 2026 American College of Toxicology (ACT) Annual Meeting
Erasca to Host Virtual Investor Event Highlighting Clinical Momentum Across Its RAS-Targeting Franchise
Radiopharm Theranostics Presents Interim Analysis from Phase 2b Imaging Study of RAD101 in Suspected Recurrent Brain Metastases Following Radiotherapy at the Society for Neuro-Oncology Annual Meeting
MacuMira Receives CE Mark for Its Microcurrent Treatment for Dry AMD
U.S. FDA Approves IGALMI® as First At-Home Acute Treatment for Agitation Associated with Schizophrenia, Schizoaffective Disorder, or Bipolar I or II Disorder in Adults
Former Cross Country Healthcare CEO Bill Grubbs Takes Expanded Role as LUKE Executive Chairman
Dr. Robert Langer, Co-Founder of Moderna, Joins PolarityBio’s Board of Directors
Galectin Therapeutics Reports September 30, 2026 Financial Results and Provides Business Update
ALX Oncology Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Apnimed Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nasus Pharma Appoints Nir Sassi as Chief Financial Officer
Iambic Provides Business Updates and Third Quarter 2026 Financial Results
Humacyte Presents Long-Term Clinical Data Demonstrating Low Atherosclerosis Susceptibility in Acellular Tissue Engineered Vessel
BioVie Presents New Biomarker Data Highlighting Biomarker-Defined Endotypes and Neuropeptide Y Response to Bezisterim at the 4th Long COVID International Conference 2026
Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Akebia Enters into Term Loan Facility with Symbiotic Capital Worth Up to $140 Million
Jasper Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Jordan Healthcare Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.